MedTrace Logo

Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers

NCT06331910 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2024-03-26

No results posted yet for this study

Summary

To evaluate Safety and efficacy of topical insulin in treatment of neurotrophic corneal ulcers

Conditions

  • Neurotrophic Keratopathy

Interventions

DRUG

insulin eye drops

Insulin eye drops deliver insulin directly to the cornea, They exploit insulin's ability to stimulate cell growth, potentially reducing healing time with minimal side effects.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-04-01
Completion
2025-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06331910 on ClinicalTrials.gov